"cancer burden" trang 3 - tải miễn phí từ tailieuXANH
Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: A case report

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: A case report
5    79    0
Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014

Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014
8    64    0
HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: A cross-sectional study

HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: A cross-sectional study
12    46    0
A simple way to measure the burden of interval cancers in breast cancer screening

A simple way to measure the burden of interval cancers in breast cancer screening
8    66    0
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
11    88    0
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study
9    77    2
Mutational concordance analysis provides supportive information for double cancer diagnosis

Mutational concordance analysis provides supportive information for double cancer diagnosis
7    56    1
The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo

The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
16    48    1
Patients with low nicotinamide Nmethyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Patients with low nicotinamide Nmethyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
10    40    1
Physician-patient communication of costs and financial burden of cancer and its treatment: A systematic review of clinical guidelines

Physician-patient communication of costs and financial burden of cancer and its treatment: A systematic review of clinical guidelines
10    198    1
Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy

Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy
11    215    1
Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States

Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States
10    20    1
Identification of a pyroptosis-related prognostic signature in breast cancer

Identification of a pyroptosis-related prognostic signature in breast cancer
16    8    1
Secular trends in incidence and mortality of cervical cancer in India and its states, 1990- 2019: Data from the Global Burden of Disease 2019 Study

Secular trends in incidence and mortality of cervical cancer in India and its states, 1990- 2019: Data from the Global Burden of Disease 2019 Study
12    15    1
CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
7    108    1
The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden

The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden
7    58    1
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
19    55    0
Disparity of perception of quality of life between head and neck cancer patients and caregivers

Disparity of perception of quality of life between head and neck cancer patients and caregivers
9    47    1
The future costs of cancer attributable to excess body weight in Brazil, 2030-2040

The future costs of cancer attributable to excess body weight in Brazil, 2030-2040
10    12    1
Socioeconomic environment and cancer incidence: A French population-based study in Normandy

Socioeconomic environment and cancer incidence: A French population-based study in Normandy
10    55    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.